BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32458599)

  • 1. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].
    Gao Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Apr; 32(2):119-122. PubMed ID: 32458599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
    Yao X; Hou Z; Cui C; Zhang M; Tu S; Li H; Liu D
    Curr Drug Metab; 2020; 21(7):534-540. PubMed ID: 32651961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
    Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
    Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
    Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential harms associated with 4-aminoquinoline treatment].
    Svensson M
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
    Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
    Medicina (B Aires); 2020; 80(3):271-274. PubMed ID: 32442941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Meo SA; Klonoff DC; Akram J
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
    Devaux CA; Rolain JM; Colson P; Raoult D
    Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
    Gao J; Tian Z; Yang X
    Biosci Trends; 2020 Mar; 14(1):72-73. PubMed ID: 32074550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
    Lentini G; Cavalluzzi MM; Habtemariam S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and COVID-19, where do we stand?
    Lecuit M
    Med Mal Infect; 2020 May; 50(3):229-230. PubMed ID: 32217166
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 May; 213():A3-A4. PubMed ID: 32247518
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chloroquine as a possible treatment for COVID-19].
    Coumou J; de Vries PJ
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.